CTX-2026, a fully human antibody, targets and binds to CD277, demonstrating an anti-tumor effect in ovarian tumor models, and is utilized in cancer research [1].
Purity:
95.00%
Target:
Others
T82664
* VAT and and shipping costs not included. Errors and price changes excepted
